Skin Acceptability Test for GINPI in Female Volunteers
Summary
NIH ClinicalTrials.gov registered Study NCT07533461, a Phase 4 clinical trial evaluating skin acceptability of the cosmetic product GINPI in healthy female adult volunteers under gynecological control. The study assesses organoleptic characteristics, subjective efficacy, and monitors for unexpected adverse events over a twice-daily application regimen for 54 participants.
What changed
NIH ClinicalTrials.gov registered a new Phase 4 clinical trial (NCT07533461) evaluating skin acceptability of the lubricating cosmetic product GINPI in healthy female adult volunteers under gynecological control. The study assesses organoleptic characteristics, subjective efficacy, and unexpected adverse events with twice-daily application.
For cosmetics manufacturers and clinical investigators, this registry entry documents a post-marketing safety evaluation for a cosmetic product. The study involves dermatological monitoring of female volunteers with skin aging or dry skin conditions, establishing a structured safety surveillance framework for consumer cosmetic use.
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Safety Test Under Gynecological Control to Evaluate Skin Acceptability of the Product in Female Volunteers
N/A NCT07533461 Kind: NA Apr 16, 2026
Abstract
The main objective of this study was to confirm skin acceptability of the product GINPI REF. GINHI BATCH: 10/06/2024 applied under normal use conditions, twice a day, in healthy female adult volunteers, under gynecological control, by means of the evaluation of organoleptic characteristics and subjective efficacy of the study product by the volunteers.
Other (secondary) objective was the assessment of unexpected adverse events referred by the volunteers as well as possible reactions observed by the investigator.
Conditions: Skin Aging, Dry Skin
Interventions: Lubricating cosmetic product
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.